Cardiovascular Systems Inc Annual Income Tax Expense (Benefit) in USD from 2015 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Cardiovascular Systems Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2015 to 2022.
  • Cardiovascular Systems Inc Income Tax Expense (Benefit) for the quarter ending December 31, 2022 was $49K, a 22.2% decline year-over-year.
  • Cardiovascular Systems Inc Income Tax Expense (Benefit) for the twelve months ending December 31, 2022 was $141K, a 56.6% decline year-over-year.
  • Cardiovascular Systems Inc annual Income Tax Expense (Benefit) for 2022 was $310K, a 23% increase from 2021.
  • Cardiovascular Systems Inc annual Income Tax Expense (Benefit) for 2021 was $252K, a 9.09% increase from 2020.
  • Cardiovascular Systems Inc annual Income Tax Expense (Benefit) for 2020 was $231K, a 21.6% increase from 2019.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $310K +$58K +23% Jul 1, 2021 Jun 30, 2022 10-K 2022-08-18
2021 $252K +$21K +9.09% Jul 1, 2020 Jun 30, 2021 10-K 2022-08-18
2020 $231K +$41K +21.6% Jul 1, 2019 Jun 30, 2020 10-K 2022-08-18
2019 $190K +$58K +43.9% Jul 1, 2018 Jun 30, 2019 10-K 2021-08-19
2018 $132K +$46K +53.5% Jul 1, 2017 Jun 30, 2018 10-K 2020-08-20
2017 $86K -$6K -6.52% Jul 1, 2016 Jun 30, 2017 10-K 2019-08-23
2016 $92K -$22K -19.3% Jul 1, 2015 Jun 30, 2016 10-K 2018-08-23
2015 $114K Jul 1, 2014 Jun 30, 2015 10-K 2017-08-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.